Latest Renewables News

LGI Limited reports a solid H1 FY25 performance with modest revenue growth and increased EBITDA, driven by expanded biogas flows and carbon abatement activities. The company confirms a positive outlook with a 12-15% underlying EBITDA growth forecast for FY25.

LGI Limited reported a 7% rise in revenue and a 3% increase in EBITDA for H1 FY25, driven by expanded power generation capacity and higher landfill gas flows. However, net profit after tax declined by 22%, reflecting ongoing investment and market dynamics.

Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.

Global Lithium Resources Limited has refreshed its board following the 2025 AGM, appointing Dr Dianmin Chen as Managing Director and CEO to spearhead strategic milestones at the Manna Lithium Project and restore investor confidence.

Touch Ventures Limited reported a substantial $24.9 million net loss for 2024, driven by impairments in legacy investments, while strategically pivoting with new stakes in Tixel and Reshop and welcoming Gannet Capital as a major shareholder.

Charter Hall Retail REIT reported a 3.0% same property net property income growth and a stable 98.7% occupancy rate in its 2025 half-year results, while integrating the Hotel Property Investments acquisition to enhance future income growth.

Meridian Energy's January 2025 report reveals a sharp drop in national hydro storage and inflows, coinciding with one of the driest Januarys on record and a notable dip in retail sales volumes.

Unibail-Rodamco-Westfield delivered robust FY-2024 results with a 7% rise in like-for-like EBITDA and adjusted recurring EPS surpassing guidance, supported by strong retail and convention business performance. The company also announced a 40% increase in its proposed dividend, reflecting confidence in its financial health and strategic asset management.

Ten Sixty Four Limited has successfully exited external administration following the full effectuation of its Deed of Company Arrangement, marking a pivotal step toward resuming normal operations and ASX trading.

Pro Medicus has delivered a record first half in FY25, driven by strong revenue growth, major contract wins, and successful implementations that position it well for future expansion.

Althea Group Holdings has sharply downgraded its FY25 financial guidance, citing significant challenges in its medicinal cannabis division and the strategic withdrawal from a vape product initiative. Despite the setback, the company highlights ongoing growth in its recreational cannabis operations and a strategic refocus on capital efficiency.

Neurotech International has inked a development deal with RH Farma to produce a pharmaceutical-grade cannabinoid drug targeting pediatric neurodevelopmental disorders, leveraging advanced European extraction technology.